The global healthcare tech-rush
Do insurers or regulators appreciate the risks around health tech? Stephen King, partner at national law firm Mills & Reeve LLP, looks why health...
Value for money healthcare
Inez Mikkelsen-Lopez and Alan Cairns explain that better information and a willingness to tackle difficult issues are necessary to ensure a fit-for-purpose and accountable...
Consolidation and Optimisation
Arnaud Sergent, partner, Serge Hovsepian, partner, and Jean-Guillaume Bayada, principal at L.E.K. Consulting, look at the rapid consolidation in France’s private healthcare market and...
Healthcare Investing Buy or Build?
Alexandre Fernandes de Oliveira, chief investment officer at IFC, examines whether it is better to grow organically or by acquisition
Several years ago, the chief...
Dialling it up
The global dialysis market is under pressure to adapt to thrive. Ploy Radford reckons that thinking big is key to survival.
The kidneys perform two...
On the cusp of major investment
L.E.K. Consulting’s Katya Zubareva, Arnaud Sergent and Jean-Guillaume
Bayada explain why the French dental market is ripe for significant private
equity investment
Historically, the French dental care...
Focus on efficiency
Healthcare chief executives need to make sure that their businesses develop and execute clear value creation, argue Andrew McKechnie, PwC strategy & healthcare leader,...
With telemedicine, there’s no place like home
Mike Griffiths, regional director of healthcare at Howden Insurance Brokers, unpicks the regulatory and liability implications of telemedicine in Singapore.
Here’s a puzzle for you:...
The little red dot
Milind Sabnis, director of healthcare, Asia Pacific, Frost & Sullivan, looks at how Singapore has become Southeast Asia’s hub for healthcare and maintains its...
Why rural healthcare matters
Inez Mikkelsen-Lopez, health specialist in the Pacific Department at the Asian Development Bank, looks at the expansion of community health posts across rural Papua...
©2020 All rights reserved LaingBuisson 
